Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma
WCLC 2022: Highlights
Colorectal cancer and precision oncology
An overview of treatment advances in gastric cancer
Optimum treatment strategy algorithm for mCRC
Bladder cancer: Current state and future directions in treatment
Optimum treatment algorithm in management of advanced prostate cancer
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022
Topics under discussion at the WCLC 2022 presidential symposium
Atezolizumab vs best supportive care in resected NSCLC
MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC
Working to improve global cancer care access in low middle-income countries